Literature DB >> 14565840

Omeprazole-induced intractable cough.

Mehran Howaizi1, Christian Delafosse.   

Abstract

OBJECTIVE: To report a case of chronic, persistent cough induced by omeprazole therapy. CASE
SUMMARY: A 42-year-old white woman presented with chronic, persistent cough after omeprazole initiation for treatment of postoperative heartburn. The cough was permanent, dry, and exhausting and worsened at night. Omeprazole therapy was continued for 4 months because the persistent cough was thought to be related to gastroesophageal reflux disease (GERD). However, no cause of persistent, chronic cough was identified. After omeprazole discontinuation, the cough resolved. DISCUSSION: The most common causes of chronic cough in nonsmokers of all ages are postnasal drip syndrome, asthma, and GERD. However, persistent cough without bronchospasm or other pulmonary involvement may occur as a drug adverse effect. According to the US omeprazole package insert, cough is observed as an adverse reaction in 1.1% of patients, although this has not been mentioned in international drug information sources or medical literature. A MEDLINE search (1966-June 2003) using the terms cough, drug related, adverse effects, and omeprazole failed to find any data. In our patient, there was a temporal relationship between cough and medication use, suggesting a causal relationship. An objective causality assessment revealed that the adverse drug reaction was probable. The mechanism is unclear.
CONCLUSIONS: Chronic, persistent cough may occur as an adverse effect of omeprazole therapy. Clinicians must be aware of this adverse effect to avoid useless and costly tests.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14565840     DOI: 10.1345/aph.1D185

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  5 in total

Review 1.  Reflux and aerodigestive tract diseases.

Authors:  Andrés Coca-Pelaz; Juan P Rodrigo; Daniela Paccagnella; Robert P Takes; Alessandra Rinaldo; Carl E Silver; Julia A Woolgar; Michael L Hinni; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-07-07       Impact factor: 2.503

2.  An experimental investigation of masking in the US FDA adverse event reporting system database.

Authors:  Hsin-wei Wang; Alan M Hochberg; Ronald K Pearson; Manfred Hauben
Journal:  Drug Saf       Date:  2010-12-01       Impact factor: 5.606

Review 3.  Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults.

Authors:  Anne B Chang; Toby J Lasserson; Justin Gaffney; Frances L Connor; Luke A Garske
Journal:  Cochrane Database Syst Rev       Date:  2011-01-19

4.  Cough: are children really different to adults?

Authors:  Anne B Chang
Journal:  Cough       Date:  2005-09-20

Review 5.  Drug-Induced Cough.

Authors:  J-S Shim; W-J Song; A H Morice
Journal:  Physiol Res       Date:  2020-03-27       Impact factor: 1.881

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.